Sex and gender in medical research: how can a focus on the individual improve health outcomes for marginalised groups?

EXPLORE

Society & Culture

© 2024 PodJoint

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/6f/69/3c/6f693c7a-fa31-7943-e085-a2c21bf648cc/mza_13248374789226510191.jpg/600x600bb.jpg

Invent: Life Sciences

TTP plc

30 episodes

4 days ago

What are the biggest challenges and opportunities facing the life sciences sector? How can we overcome these challenges while unlocking the opportunities? Join host Stuart Lowe and a roster of expert guests as they unpack the past, present and future of cell and gene therapy.

Show more...

All content for Invent: Life Sciences is the property of TTP plc and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

What are the biggest challenges and opportunities facing the life sciences sector? How can we overcome these challenges while unlocking the opportunities? Join host Stuart Lowe and a roster of expert guests as they unpack the past, present and future of cell and gene therapy.

Show more...

https://files.cohostpodcasting.com/quill-file-prod/64e9f6c3-9e03-4919-9065-c158d298722c/shows/640487af-a806-489d-b996-f8b6fd7191d1/episodes/6036b586-cc44-4270-94ba-6dc4dd2e651e/cover-art/original_657d28508a86a8b93990ca50fbe0246a.jpg

Sex and gender in medical research: how can a focus on the individual improve health outcomes for marginalised groups?

Invent: Life Sciences

35 minutes 36 seconds

2 years ago

Sex and gender in medical research: how can a focus on the individual improve health outcomes for marginalised groups?

Throughout almost all of medical history, it was assumed that the average white male response to drug trials could be extrapolated to all potential recipients. But when we look at the poorer health outcomes for women and minorities, could the underlying assumptions in medical research be a contributing factor? If so, what is being done to solve them?

To find out, join us on Invent: Life Sciences, a podcast brought to you by technology and product development company TTP.

This Week's Guests
Diana Torgersen
Diana Torgersen is the Executive Director for External Innovation & Emerging Science at Organon. Organon is a global healthcare company with a portfolio of therapies and product's in women's health, biosimilars, and established medicines across a wide array of conditions and diseases.

Shirin Heidari
Shirin Heidari is the Founding President of GENDRO, a not-for-profit organisation with a mission to advance equity through sex and gender senstive-research across discplines by creating public awareness about the implications of lack of sex and gender considerations in research and innovation.

Deana Mohr
Deana Mohr is CEO of MUVON Therapeutics. MUVON Therapeutics is a clinical stage Life Science spin-off from the University of Zurich developing a therapeutic platform for the regeneration of skeletal muscle tissue based on autologous cells, not only repairing damaged tissue but also increasing the regenerative potential of weakened muscles.